Details of the Drug Combinations

General Information of This Drug (ID: DMKJDR6)

Drug Name

VX-702 DMKJDR6

Synonyms

ST51054128; I14-1965; EC-000.2363; 6-[carbamoyl-(2,6-difluorophenyl)amino]-2-(2,4-difluorophenyl)pyridine-3-carboxamide

Indication

Disease Entry	ICD 11	Status	REF
Coronary artery disease	BA80	Phase 2a	[1]
Rheumatoid arthritis	FA20	Phase 2a	[1]
Inflammation	1A00-CA43.1	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

2 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
VX-702 + Marizomib	DCGTMUB	Marizomib	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[2]
VX-702 + Idarubicin	DCNCGP1	Idarubicin	Glioblastoma? (Cell Line: T98G)	[2]
------------------------------------------------------------------------------------

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6059).
2	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.